GlassScriptPhysician profile
Reeva Salkin
NPI 1245584911
$546.18
in general payments reported to CMS, 2019-2025
16 companies · $13.59 in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2023: $220 · 2024: $191 · 2025: $13.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $122.02 | 2021 | |
| Abbvie INC. | $94.16 | 2023-2025 | |
| Sk Life Science, INC. | $58.58 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $46.30 | 2023-2024 | Austedo Xr |
| Alexion Pharmaceuticals, INC. | $32.75 | 2023 | Ultomiris |
| Genentech USA, INC. | $27.83 | 2024 | Ocrevus, Enspryng |
| Eisai INC. | $20.05 | 2023 | |
| Neurocrine Biosciences, INC. | $18.71 | 2024 | Ingrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.59 | 2024 | Jardiance |
| Merz Pharmaceuticals, LLC | $16.70 | 2024 | Xeomin |
| Ucb, INC. | $16.43 | 2023 | Briviact |
| Lundbeck LLC | $15.92 | 2023 | Vyepti |
| Ani Pharmaceuticals, INC. | $15.45 | 2024 | Purified Cortrophin Gel |
| Neurelis, INC. | $14.74 | 2023 | Valtoco |
| Argenx US, INC. | $14.70 | 2023 | Vyvgart |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $14.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reeva Salkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.